Trial
NCT04747470
Study to Assess the Effects of GS-3583 in Participants With Advanced Solid Tumors
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Gilead Sciences
Collaborators
—
Condition
Advanced Solid Tumors
Intervention
GS-3583
Why stopped
Sponsor decision to prematurely discontinue the study, following an internal safety assessment of the molecule, GS-3583.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-03